Artivion | CRY - Operating Expenses


Artivion reported $111.2M in Operating Expenses for its fiscal quarter ending in December of 2025.





Operating Expenses Change Date
Abbott USD 9.21B 17M Dec/2025
Accuray USD 37.18M 567K Dec/2024
AngioDynamics USD 81.95M 1.68M Sep/2025
Artivion USD 111.2M 9.45M Dec/2025
AtriCure USD 138.01M 3.95M Dec/2025
Baxter International USD 3.19B 554.4M Dec/2025
Becton, Dickinson and Co. USD 4.59B 476M Dec/2025
Boston Scientific USD 4.04B 18M Dec/2025
Edwards Lifesciences USD 1.2B 71.3M Dec/2025
Inogen USD 49.14M 665K Sep/2024
Integra LifeSciences USD 368.92M 668.65M Dec/2025
J&J USD 18.97B 2.38B Dec/2025
Mesa Laboratories USD 33.98M 2.03M Dec/2024
Orthofix International USD 213.79M 12.36M Dec/2025
Pfizer USD 12.91B 79.89B Dec/2025
ResMed USD 925.21M 51.98M Dec/2025
Stryker USD 5.2B 505M Dec/2025
Surmodics USD 29.51M 274.86M Jun/2025
Tandem Diabetes Care USD 282.09M 9.97M Dec/2025
Teleflex USD 532.64M 3.29B Dec/2025
Terumo JPY 252.74B 22.88B Dec/2025
Trinity Biotech USD 14.82M 7.81M Sep/2025